Analysis of MDR1 expression in normal and malignant endometrium by reverse transcription-polymerase chain reaction and immunohistochemistry

Clinical Cancer Research

Volumn 2, Issue 12, 1996, Pages 1981-1992

  Kuo, Dennis Yi Shin ^a   Mallick, Shyamali ^b   Shen, Heng Jia ^b   DeVictoria, Carol ^a   Jones, Joan ^b   Fields, Abbie L ^a   Goldberg, Gary L ^a   Runowicz, Carolyn D ^a   Horwitz, Susan Band ^b,c  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MENOPAUSE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; P-GLYCOPROTEIN; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0030474493     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Bradley, G., and Ling, V. P-glyeoprotein, multidrug resistance, and tumor progression. Cancer Metastasis Rev., 13: 223-233, 1994.
2. Chin, K., V , Pastan, I., and Gottesman, M M. Function and regulation of the human multidrug resistance gene. Adv. Cancer Res., 60: 157-180, 1993.
3. Kessel, D., Botterall, V., and Wodinsky, I. Uptake and retention of daunomycin by mouse leukemic cells as factor in drug response. Cancer Res., 28: 938-941, 1968.
4. Dano, K. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim. Biophys. Acta, 323: 466-483, 1973.
5. Juliano, R. L., and Ling, V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary mutants. Biochem. Biophys. Res. Commun., 455: 152-162, 1976.
6. Chin, J. E., Soffir, R., Noonan, K. E., Choi, K., and Roninson, I. B. Structure and expression of the human MDR (P-glycoprotein) gene family. Mol. Cell. Biol., 9: 3808-3820, 1989.
7. van der Bliek, A. M., Baas, F., Ten Houte de Lange, T., Kooiman, P. M., van der Velde-Koerts, T., and Borst, P. The human mdr3 gene encodes a novel P-glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver. EMBO J., 6: 3325-3331, 1987.
8. van der Bliek, A. M., Kooiman, P. M., Schneider, C., and Borst, P. Sequence of mdr3 cDNA encoding a human P-glycoprotein. Gene (Amst.), 71: 401-411, 1988.
9. Hsu, S., Cohen, D., Kirschner, L., Lothstein, L., Hartstein, M., and Horwitz, S. Structural analysis of the mouse mdr1a (P-glycoprotein) promoter reveals the basis for differential transcript heterogeneity in multidrug-resistant J774.2 cells. Mol. Cell. Biol., 10: 3596-3606, 1990.
10. Gros, P., Raymond, M., Bell, J., and Housman, D. Cloning and characterization of a second member of the mouse mdr gene family. Mol. Cell. Biol., 8: 2770-2778, 1988.
11. Kartner, N., Evernden, P. D., Bradley, G., and Ling, V. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature (Lond.), 316: 820-823, 1985.
12. Cordon-Cardo, C., O'Brien, J. P., Boccia, J., Casals, D., Bertino, J. R., and Melarned, M. R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem., 38: 1277-1287, 1990.
13. Sugawara, I., Ohkochi, E., Hamada, H., Tsuruo, T., and Mori, S. Cellular and tissue distribution of MRK20 murine monoclonal antibody-defined 85-kDa protein in Adriamycin-resistant cancer cell lines. Jpn. J. Cancer Res., 79: 1101-1110, 1988.
14. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Paslan, I., and Willingham, M. C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci., USA, 84: 7735-7738, 1987.
15. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., and Willinghain, M. C. Immunohistochemical localization in normal tissues of different epitopes in the multidrug-transport protein P170: evidence for localization in brain capillaries and cross-reactivity of one antibody with a muscle protein. J. Histochem. Cytochem., 37: 159-164, 1989.
16. Croop, J. M., Raymond, M., Huber, D., DeVault, A., Arceci, R. J., Gros, P., and Housman, D. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol. Cell. Biol., 9: 1346-1350, 1989.
17. Schinkel, A. H., Smit, J. J. M., van Tellmgen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Walk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., Berns, A. J. M., and Borst, P. Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell, 77: 491-502, 1994.
18. Smit, J. J., Schinkel, A. H., Oude Efferink, R. P. J., Groen, A. K., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., Ottenhoff, R., van der Lugt, N. M. T., van Roon, M. A., van der Valk, M. A., Offenhaus, G. J. A., Berns, A. J. M., and Borst, P. Homozygous disruption of the murme mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell, 75. 451-462, 1993.
19. Bell, D., Gerlach, J., Kartner, N., Buick, R., and Ling, V. Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. J. Clin. Oncol., 3: 311-315, 1985.
20. Fojo, A., Shen, D., Mickley, L., Pastan, I., and Gottesman, M. Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene. J. Clin. Oncol, 5: 1922-1927, 1987.
21. Bourhis, J., Benard, J., Hartmann, O., Boccoru G., Lemerle, J., and Riou, G. Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. J. Natl. Cancer Inst., 81: 1401-1405, 1989.
22. Goldstein, L., Galski, H., Fojo, A., Willingham, M., Lai, S., Gazdar, A., Pirker, R., Green, A., Crist, W., and Brodeur, G. Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst., 81: 116-124, 1989.
23. Lum, B., Gosland, M., Kaubisch, S., and Sikic, B. Molecular target in oncology: implications of the multidrug resistance gene. Pharmacotherapy. 13: 89-109, 1993.
24. Shen, D. W., Fojo, A., Chin, J. E., Roninson, I. B., Richert, N., Pastan, I., and Gottesman, M. M. Human multidrug-resistam cell lines: increased mdr1 expression can precede gene amplification. Science (Washington DC), 232: 643-645, 1986.
25. Chan, H. S., Haddad, G., Thorner, P. S., DeBoer, G., Lin, Y. P., Ondrusek, N., Yeger, H., and Ling, V. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N. Engl. J. Med., 325: 1608-1614, 1991.
26. Chan, H. S., Thorner, P. S., Haddad, G., and Gallie, B. L. Multidrug-resistant phenotype in retinoblastoma correlates with P-glycoprotein expression. Ophthalmology, 98: 1425-1431, 1991.
27. Chan, H. S., Thorner, P. S., Haddad, G., and Ling, V. Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J. Clin. Oncol., 8: 689-704, 1990.
28. Dalton, W. S., Grogan, T. M., and Miller, T. P. The role of P-glycoprotein in drug-resistant hematologic malignancies. Cancer Treat. Res., 57: 187-208, 1991.
29. Arceci, R. J., Croop, J. M., Horwitz, S. B., and Housman, D. The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc. Natl. Acad. Sci. USA. 85: 4350-4354, 1988.
30. Arceci, R. J., Baas, F., Raponi, R., Horwitz, S. B., Housman, D., and Croop, J. Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus. Mol. Reprod. Dev., 25: 101-109, 1990.
31. Axiotis, C. A., Monteagudo, C., Merino, M. J., LaPorte, N., and Neumann, R. D. Immunohistochemical detection of P-glycoprotein in endometrial adenocarcinoma. Am. J. Pathol., 138: 799-806, 1991.
32. Kodama, J., Ryoji, H., Okuda, H., Yoshinouchi, M., and Kudo, T. Reverse correlation between P-glycoprotein and proliferative activity in endometrial adenocarcinoma. Eur. J. Obstet. Gynecol. Reprod. Biol., 59: 45-51, 1995.
33. Schneider, J., Efferth, T., Rodriguez-Escudero, F. J., and Volm, M. Intrinsic overexpression of two different mechanisms of resistance to chemotherapy (P-glycoprotein and GST-a) in human endometrial carcinoma. Chemotherapy. 40: 265-271, 1994.
34. Axiotis, C., Guarch, R., Merino, M., LaPorte, N., and Neumann, R. D. P-glycoprotein expression is increased in the human secretory and gestational endometrium. Lab. Invest., 65: 577-581, 1991.
35. Connelly, P. J., Albershasky, R C., and Christopherson, W. W. Carcinoma of the endometrium. III. Analysis of 865 cases of adenocarcincoma and adenocanthoma. Obstet. Gynecol., 59: 569-574, 1982.
36. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
37. Horikoshi, T., Danenberg, K. D., Stadlbauer, T. H. W., Volkenandt, M., Shea, L. C. C., Aigner, K., Gustavsson, B., Leichman, L., Prosing, R., Ray, M., Gibson, N. W., Spears, C. P., and Danenberg, P. V. Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res., 52: 108-116, 1992.
38. Guillem, J. G., Levy, M. F., Hsieh, L. L., Johnson, M. D., LoGerfo, P., Forde, K. A., and Weinstein, I. B. Increased levels of phorbin, c-myc, and ornithine decarboxylase. RNAs in human colon cancer. Mol. Carcinog., 3: 68-74, 1990
39. Henrik, C. J., Nyholm, M. D., Nielsen, A. L., Lyndrug, J., Norup, P., and Thorpe, S. M. Biochemical and immunohistochemical estrogen and progesterone receptors in adenomatous hyperplasia and endometrial carcinoma: correlations with stage and other clinicopathologic features. Am. J. Obstet. Gynecol., 167: 1334-1342, 1992.
40. Nyholm, H. C. J., Nielsen, A. L., Lyndrup, J., Dreisler, A., and Thorpe, S. M. Estrogen and progesterone receptors in endometrial carcinoma: comparison of immunohistochemical and biochemical analysis. Int. J. Gynecol. Pathol., 12: 246-252, 1993.
41. Creasman, W. Prognostic significance of hormone receptors in endometrial cancer. Cancer (Phila.), 71: 1467-1470, 1993.
42. Vecek, N., Nola, M., Marusic, M., Ilic, J., Babic, D., Petrovecki, M., Nikolic, S., Marinovic, T., Jukic, D., and Vecek, N. J. Prognostic value of steroid hormone receptors concentration in patients with endometrial carcinoma. Acta Obstet. Gynecol. Scand., 73: 730-733, 1994.
43. Piekarz, R., Cohen, D., and Horwitz, S. Progesterone regulates the murine multidrug resistance mdr1b gene. J. Biol. Chem., 268: 7613-7616, 1993.
44. Gros, P., and Buschman, E. The mouse multidrug resistance gene family: structural and functional analysis. Int. Rev. Cytol., 137: 169-197, 1993.
45. Gottesman, M. M., and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62: 385-427, 1993.
46. Hsu, S. I., Lothstein, L., and Horwitz, S. B. Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. Evidence that distinct P-glycoprotein precursors are encoded by unique mdr genes. J. Biol. Chem., 264: 12053-12062, 1989.
47. Brophy, N. A., Marie, J. P., Rojas, V. A., Warnke, R. A., McFall, P. J., Smith, S. D., and Sikic, B. I. Mdr1 gene expression in childhood acute lymphoblastic leukemias and lymphomas: a critical evaluation by four techniques Leukemia (Baltimore), 8: 327-335, 1994.
48. van Kalkan, C. K., van der Walk, P., and Hadisaputro, M. M. N. Differentiation-dependent expression of P-glycoprotein in normal and neoplastic kidney. Ann. Oncol., 2: 55-62, 1991.
49. Cianfriglia, M., Willingham, M. C., Tombesi, M., Scagliotti, G. V., Frasca, G., and Chersi, A. P-glycoprotein epitope mapping. I. Identification of a linear human-specific epitope in the fourth loop of the P-glycoprotein extracellular domain by MM4.17 tnurine monoclonal antibody to human multidrug-resistant cells. Int. J. Cancer, 56: 153-160, 1994.
50. Grogan, T., Dalton, W., Rybski, I., Spier, C., Meltzer, P., Richter, L., Gleason, M., Pindur, J., Cline, A., Scheper, R., Tsuruo, T., and Salmon, S. Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies. Lab. Invest., 63: 815-823, 1990.
51. Schneider, J., Efferth, T., Centeno, M., Mattern, J., Rodriguez-Escudero, F., and VoIm, M. High rate of expression of multidrug resistance-associated P-glycoprotein in human endometrial carcinoma and normal endometrial tissue. Eur. J. Cancer. 29: 554-558, 1993.